{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:59:28Z","timestamp":1775833168819,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.thromres.2024.109229","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T21:27:10Z","timestamp":1732051630000},"page":"109229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The contact system in chronic kidney disease and hemodialysis \u2013 A cross-sectional study"],"prefix":"10.1016","volume":"245","author":[{"given":"Yaseelan","family":"Palarasah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Else-Marie","family":"Bladbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie Thuy Duong","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Mejldal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Bo","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Bruno","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle Charlotte","family":"Thiesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5746-8489","authenticated-orcid":false,"given":"Katrine","family":"Pilely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2024.109229_bb0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","article-title":"Epidemiology of haemodialysis outcomes","volume":"18","author":"Bello","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.thromres.2024.109229_bb0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: report of a kidney disease: improving global outcomes (KDIGO) consensus conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int."},{"issue":"10041","key":"10.1016\/j.thromres.2024.109229_bb0015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(16)30448-2","article-title":"Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices","volume":"388","author":"Robinson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2024.109229_bb0020","article-title":"Hemodialysis-related complement and contact pathway activation and cardiovascular risk: a narrative review","author":"Skinner","year":"2021","journal-title":"Published online"},{"key":"10.1016\/j.thromres.2024.109229_bb0025","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1046\/j.1523-1755.2001.00009.x","article-title":"Role of contact system activation in hemodialyzer-induced thrombogenicity","volume":"60","author":"Frank","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2024.109229_bb0030","first-page":"S62","article-title":"Hemodialysis membranes: interleukins, biocompatibility, and middle molecules","volume":"13 Suppl 1(SUPPL. 1)","author":"H\u00f6rl","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.thromres.2024.109229_bb0035","article-title":"Cardiovascular disease in haemodialysis: role of the intravascular innate immune system","author":"Ekdahl","year":"2017","journal-title":"Published online"},{"issue":"76","key":"10.1016\/j.thromres.2024.109229_bb0040","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1046\/j.1523-1755.2000.07613.x","article-title":"Clinical relevance of cytokine production in hemodialysis","volume":"58","author":"Pertosa","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2024.109229_bb0045","article-title":"Clotting of the extracorporeal circuit in hemodialysis: beyond contact-activated coagulation","author":"Engelen","year":"2023","journal-title":"Published online"},{"issue":"5","key":"10.1016\/j.thromres.2024.109229_bb0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0003319713483000","article-title":"Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4","volume":"65","author":"Ghanavatian","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.thromres.2024.109229_bb0055","unstructured":"Annuk M, Soveri I, Zilmer M, Lind L, Hulthe J, Fellstr\u00f6m B. Endothelial function, CRP and oxidative stress in chronic kidney disease. J. Nephrol. 2005;18(6):721\u2013726. Accessed January 25, 2024. https:\/\/europepmc.org\/article\/med\/16358230."},{"key":"10.1016\/j.thromres.2024.109229_bb0060","doi-asserted-by":"crossref","unstructured":"Wanner C, Amann K, Shoji T. Dialysis 1 the heart and vascular system in dialysis. www.thelancet.com. 2016;388. doi:https:\/\/doi.org\/10.1016\/S0140-6736(16)30508-6.","DOI":"10.1016\/S0140-6736(16)30508-6"},{"issue":"8","key":"10.1016\/j.thromres.2024.109229_bb0065","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0036-1598003","article-title":"Factor XII contact activation","volume":"43","author":"Naudin","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.thromres.2024.109229_bb0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.arcmed.2005.08.001","article-title":"Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system","volume":"37","author":"Sharma","year":"2006","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.thromres.2024.109229_bb0075","doi-asserted-by":"crossref","unstructured":"Chao J, Shen B, Gao L, Xia CF, Bledsoe G, Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. In: Biological Chemistry. Vol 391. Biol. Chem.; 2010:345\u2013355. doi:https:\/\/doi.org\/10.1515\/BC.2010.042.","DOI":"10.1515\/bc.2010.042"},{"issue":"3","key":"10.1016\/j.thromres.2024.109229_bb0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jth.13235","article-title":"Contact system revisited: an interface between inflammation, coagulation, and innate immunity","volume":"14","author":"Long","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2024.109229_bb0085","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.bbamcr.2017.07.009","article-title":"The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity","volume":"1864","author":"Weidmann","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.thromres.2024.109229_bb0090","article-title":"In vivo roles of factor XII factor XII is dispensable for hemostasis","author":"Renn\u00e9","year":"2012","journal-title":"Published online"},{"issue":"3","key":"10.1016\/j.thromres.2024.109229_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anai.2010.01.007","article-title":"The bradykinin-forming cascade and its role in hereditary angioedema","volume":"104","author":"Kaplan","year":"2010","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.thromres.2024.109229_bb0100","first-page":"9","article-title":"Plasma Kallikrein cleaved H-kininogen: an end-point marker for contact activation in vitro and ex vivo","author":"Palarasah","year":"2022","journal-title":"Front Cardiovasc Med."},{"issue":"AUG","key":"10.1016\/j.thromres.2024.109229_bb0105","article-title":"Plasminflammation\u2014an emerging pathway to bradykinin production","volume":"10","author":"Maas","year":"2019","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.thromres.2024.109229_bb0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"issue":"34","key":"10.1016\/j.thromres.2024.109229_bb0115","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1016\/j.biomaterials.2009.07.052","article-title":"Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces","volume":"30","author":"B\u00e4ck","year":"2009","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.thromres.2024.109229_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1067\/mlc.2001.116486","article-title":"Contact between a polymer and whole blood: sequence of events leading to thrombin generation","volume":"138","author":"Hong","year":"2001","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.109229_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0142-9612(99)00145-3","article-title":"In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response","volume":"21","author":"Lamba","year":"2000","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.thromres.2024.109229_bb0130","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s10856-013-5002-6","article-title":"Factor XII activation markers do not reflect FXII dependence of thrombin generation induced by polyvinylchloride","volume":"24","author":"Frank","year":"2013","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.thromres.2024.109229_bb0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1523-1755.1999.0550031097.x","article-title":"Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH","volume":"55","author":"Renaux","year":"1999","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.thromres.2024.109229_bb0140","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1681\/ASN.V391563","article-title":"Bradykinin generation by dialysis membranes","volume":"3","author":"Schulman","year":"1993","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.thromres.2024.109229_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s001340050288","article-title":"Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways","volume":"23","author":"Salmon","year":"1997","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.thromres.2024.109229_bb0150","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ekir.2020.03.010","article-title":"Hemodialysis does not induce detectable activation of the contact system of coagulation","volume":"5","author":"Fran\u00e7ois","year":"2020","journal-title":"Kidney Int Rep."},{"issue":"5","key":"10.1016\/j.thromres.2024.109229_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc5080","article-title":"The effects of continuous venovenous hemofiltration on coagulation activation","volume":"10","author":"Bouman","year":"2006","journal-title":"Crit. Care"},{"issue":"7","key":"10.1016\/j.thromres.2024.109229_bb0160","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/00365519609090600","article-title":"Activation of FXII during haemodialysis","volume":"56","author":"Svensson","year":"1996","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"4","key":"10.1016\/j.thromres.2024.109229_bb0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000217449","article-title":"Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure","volume":"27","author":"Matsuo","year":"1997","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"7","key":"10.1016\/j.thromres.2024.109229_bb0170","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/HJH.0000000000000192","article-title":"Coagulation FactorXIIa-kinin-mediated contribution to hypertension of chronic kidney disease","volume":"32","author":"Papageorgiou","year":"2014","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.thromres.2024.109229_bb0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/01971529608005783","article-title":"An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma","volume":"17","author":"Ford","year":"1996","journal-title":"J. Immunoass."},{"issue":"6","key":"10.1016\/j.thromres.2024.109229_bb0180","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0272-6386(12)80136-3","article-title":"Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis","volume":"23","author":"Vaziri","year":"1994","journal-title":"Am. J. Kidney Dis."},{"issue":"15","key":"10.1016\/j.thromres.2024.109229_bb0185","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.clinbiochem.2016.06.011","article-title":"Calibrated kallikrein generation in human plasma","volume":"49","author":"Biltoft","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.thromres.2024.109229_bb0190","doi-asserted-by":"crossref","unstructured":"Elm E von, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335(7624):806\u2013808. doi:https:\/\/doi.org\/10.1136\/BMJ.39335.541782.AD.","DOI":"10.1136\/bmj.39335.541782.AD"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2024.109229_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jim.2013.04.012","article-title":"ELISA for determination of total coagulation factor XII concentration in human plasma","volume":"394","author":"Madsen","year":"2013","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.thromres.2024.109229_bb0200","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.bbagen.2015.03.005","article-title":"C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: implication for a role in hereditary angioedema","volume":"1850","author":"Madsen","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.thromres.2024.109229_bb0205","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1055\/a-1346-3384","article-title":"Effect of anabolic-androgenic steroid abuse on the contact activation system","volume":"121","author":"Sidelmann","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2024.109229_bb0210","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI98869","article-title":"Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema","volume":"129","author":"Haslund","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2024.109229_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2017.02.002","article-title":"A novel antihuman C3d monoclonal antibody with specificity to the C3d complement split product","volume":"444","author":"Rasmussen","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.thromres.2024.109229_bb0220","first-page":"9(JAN)","article-title":"The complement system in dialysis: a forgotten story?","author":"Poppelaars","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109229_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-017-0519-4","article-title":"Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system","volume":"18","author":"Vitova","year":"2017","journal-title":"BMC Nephrol."},{"issue":"7","key":"10.1016\/j.thromres.2024.109229_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180964","article-title":"Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus","volume":"12","author":"Wheelock","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.thromres.2024.109229_bb0235","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00125-020-05144-1","article-title":"Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes","volume":"63","author":"H\u00e4rma","year":"2020","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.thromres.2024.109229_bb0240","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ki.2013.8","article-title":"Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes","volume":"83","author":"Merchant","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2024.109229_bb0245","first-page":"125","article-title":"Elevated plasma FXII is associated with disease activity in ANCA-associated vasculitis: a retrospective cross-sectional study in Western China","author":"Chen","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.thromres.2024.109229_bb0250","first-page":"223","article-title":"The role of intrinsic fibrinolytic system activation in pathogenesis of hemostasis disturbances in Hemodialized patients with chronic renal failure","volume":"26","author":"Bronisz","year":"2004","journal-title":"Jacek Manitius & Edmund Nartowicz."},{"issue":"2","key":"10.1016\/j.thromres.2024.109229_bb0255","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1681\/ASN.2011030287","article-title":"Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis","volume":"23","author":"Gambo","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.thromres.2024.109229_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.thromres.2023.07.007","article-title":"Estimation of the preanalytical activation of the contact system in coagulation tubes","volume":"229","author":"Kristensen","year":"2023","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482400361X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482400361X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:33:27Z","timestamp":1735238007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482400361X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":52,"alternative-id":["S004938482400361X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109229","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contact system in chronic kidney disease and hemodialysis \u2013 A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109229"}}